We are live on
!
Find out more
CII
Capital International Inc Portfolio holdings
AUM
$13B
1-Year Est. Return
31.88%
This Fund
S&P 500
This Quarter
Est. Return
-1.17%
1 Year Est. Return
+31.88%
3 Year Est. Return
+109.21%
5 Year Est. Return
+147.21%
10 Year Est. Return
+829.94%
AUM
$2.75B
AUM Growth
–
Cap. Flow
+$2.83B
Cap. Flow
% of AUM
103.02%
Top 10 Holdings %
Top 10 Hldgs %
35.38%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$145M |
| 2 |
Banco Bradesco
BBD
|
+$138M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$103M |
| 4 |
ICICI Bank
IBN
|
+$92.4M |
| 5 |
Gerdau
GGB
|
+$87.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 17.21% |
| 2 | Healthcare | 11.75% |
| 3 | Communication Services | 11.28% |
| 4 | Energy | 10.89% |
| 5 | Consumer Discretionary | 8.89% |
Similar funds
AAMU
NMIFOAC
GC
TRSOTSOK
AB
PFPG
AIM
TWIM
Capital International Inc's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital International Inc, which disclosed 105 positions worth $2.75B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Gilead Sciences: 2,781,600 shares worth $142M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, followed by Healthcare and Communication Services.
- Capital International Inc's largest Q2 2013 buy was Gilead Sciences: 2,781,600 shares worth $142M.
- Capital International Inc's ten largest holdings make up 35% of its $2.75B portfolio in Q2 2013.
- Capital International Inc disclosed 105 positions in Q2 2013, its first 13F filing on record.
Based on Capital International Inc's 13F filing for Q2 2013, filed 14 Aug 2013.